PITCH is Collision’s startup competition that brings together the world’s leading early-stage startups to battle it out onstage.
PITCH is open to any ALPHA and BETA startups exhibiting at Collision that have received less than $5 million in funding to date and have not had a discernible change in business model in the last three years.
After a two rounds of pitching a B.C. startup has landed itself one of three spots in the 2024 PITCH final.
Victoria’s VoxCell BioInnovation, pitched by Asees Kaur (above), joins Toronto’s Biofect Innovations and Proceve for the final pitch off on Thursday as Collision wraps up its time in Toronto.
VoxCell is a leader in the field of tissue engineering and announced the launch of its first product, the Universal Bioink Kit, yesterday at Collision.
VoxCell was named one of Techcouver’s 10 homegrown startups to watch in 2023.
The Universal Bioink Kit is designed to revolutionize the 3D bioprinting landscape by providing a versatile and reliable bioink that mimics the extracellular matrix of living tissues.
The kit stands out due to its unique ability to replicate the chemical and mechanical properties of soft tissues, offering unmatched compatibility with various bioprinting technologies, including extrusion-based and digital light processing (DLP) systems.
This ready-to-use bioink supports multiple media compatibility, allowing researchers to work with a variety of cell lines and unlock new possibilities in tissue engineering.
Leave a Reply